How the Patient Risk Stratification Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Drivers Are Shaping the Growth and Development of thePatient Risk Stratification Market?
The continued increase in chronic diseases is anticipated to drive the expansion of the patient risk stratification market in the future. Chronic diseases are enduring health issues that last for prolonged periods, typically beyond three months. The rising incidence of chronic diseases is largely due to factors such as an aging populace, unhealthy living habits, urban development, environmental impacts, inadequate healthcare access, economic inequalities, and elevated stress levels. Patient risk stratification facilitates the identification of individuals with varying levels of risk for chronic diseases, permitting tailored care, early interventions, optimal distribution of resources, and enhancing health outcomes. For example, in January 2023, the National Center for Biotechnology Information (NCBI), part of the U.S. National Library of Medicine, projected a 99.5% increase in the population of individuals 50 years and older with at least one chronic disease. This growth is expected to rise from 71.522 million in 2020 to 142.66 million by 2050. Additionally, the World Health Organization’s (WHO) 2022 Highlights in September 2022 reported that chronic diseases were responsible for 74% of all global deaths, totaling 41 million annually. Cardiovascular diseases resulted in 17.9 million deaths, cancer was the cause of 9.3 million, chronic respiratory diseases induced 4.1 million, and diabetes led to 2.0 million deaths. Therefore, the escalating prevalence of chronic diseases fuels the patient risk stratification market’s expansion.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20917&type=smp
#What Long-Term Growth Rate is Expected for thePatient Risk Stratification Market Between 2025 and 2034?
There has been a remarkable surge in the size of the patient risk stratification market in the last few years. Projected to expand from $2.15 billion in 2024 to $2.82 billion in 2025, the market is set to flourish at a compound annual growth rate (CAGR) of 31.3%. The spurt during the past years was driven by several factors, including enhanced digitization, escalated risk factors, an increase in elderly populations, a high prevalence of medical errors, and an upswing in the use of electronic health records (EHR).
The market size of patient risk stratification is anticipated to witness a significant rise in the coming years, expanding to an anticipated $8.30 billion by 2029 with an impressive Compound Annual Growth Rate (CAGR) of 31.0%. The underlying causes for this projected growth rate during the forecast period can be related to the burgeoning middle-class population and health insurance rates, rise in chronic disease incidences, the widespread uptake of predictive analytics, an increasing focus on social determinants of health (SDOH), and the broadening application of technology. The period under review is expected to be marked by advancements and inroads in analytics, artificial intelligence (AI), machine learning, technological breakthroughs, pioneering tools, evolution in the healthcare technology sector, wearable tech, and remote monitoring.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20917
Which Cutting-Edge Market Trends Are Expected to Drive thePatient Risk Stratification Market’s Growth?
Key companies within the patient risk stratification market are turning their attention towards technological enhancements within the healthcare sector, including the implementation of artificial intelligence (AI) for disease screening. The objective is to enhance early detection capacities, improve patient outcomes, and curtail healthcare expenses by facilitating more precise risk evaluations and individualized treatment programs. The application of AI in disease screening capitalizes on advanced algorithms and machine learning to scrutinize medical data, thus enabling the early detection of diseases and improving the precision of diagnoses by rapidly processing large volumes of data. For example, in May 2024, WELL Health Technologies Corporation, a healthcare company located in Canada, alongside its investee company HEALWELL AI, which is also Canada-based and centers its operations on AI and data science for preventative care, inaugurated WELL AI Decision Support (WAIDS). The program targets rare diseases and has extended its scope to chronic conditions such as kidney disease, hypertension, and diabetes. It has the capacity to identify over 100 diseases and offer risk stratification, aiding clinicians in recognizing gaps in care and obtaining actionable data during patient interaction.
What Are the Leading Market Players Impacting thePatient Risk Stratification Market’s Growth Trend?
Major companies operating in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report
How Are the Key Segments of the Patient Risk Stratification Market Driving Opportunities and Innovations?
The patient risk stratification market covered in this report is segmented –
1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model
2) By Component: Software, Services
3) By Delivery Model: On-Premise, Cloud-Based
4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications
5) By End User: Healthcare Providers, Healthcare Payers, Other End Users
Subsegments:
1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models
2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models
3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models
4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20917&type=smp
What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of thePatient Risk Stratification Market?# Market Expansion?
North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Patient Risk Stratification Market 2025, By The Business Research Company:
Patient Portal Global Market Report 2025
https://thebusinessresearchcompany.com/report/patient-portal-global-market-report
Global Patient Safety And Risk Management Software Global Market Report 2025
Patient Registry Software Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/patient-registry-software-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
